about
sameAs
Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)Potentiation of the T-lymphocyte response to mitogens. I. The responding cellDNA array analysis of interleukin-2-regulated immediate/early genesThe quantal theory of how the immune system discriminates between "self and non-self"Revisiting the first long-term culture of antigen-specific cytotoxic T cellsIL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Inhibition of the mitogenic response of normal peripheral lymphocytes by extracts or supernatant fluids of a Herpesvirus saimiri lymphoid tumor cell line.The definition of lymphocyte activating factor: giving a helping hand to serendipity.Acute inflammation. A review.Human mixed leukocyte culture: identification of the proliferating lymphocyte subpopulation by sex chromosome markers.Autophagy is required for IL-2-mediated fibroblast growth.Immunotherapeutic strategies to target prognostic and predictive markers of cancer.Following the cytokine signaling pathway to leukemogenesis: a chronologyRecent advances in cytokines: therapeutic implications for inflammatory bowel diseases.Toward a molecular understanding of adaptive immunity: a chronology, part I.In vitro end points for the assessment of cellular immune response-modulating drugs.The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.Scientific scholarship and impact factors.Biological properties of lymphokines.Mitogenic factor from chronically infected guinea pigs.Affinity of antigen for white cells and its relation to the induction of antibody formation.Activation of lymphocytes.Interleukin 12: cellular and molecular immunology of an important regulatory cytokine. Introduction.A historical personal perspective on human retroviruses and their infection of T cells.Products of lymphoid cells in continuous culture.Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.Conditional IL-2 Gene Deletion: Consequences for T Cell Proliferation.The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products.IL-2 and Beyond in Cancer Immunotherapy.Etymologia: Cytokines.
P2860
Q24679256-D32A1B64-D42B-4778-9BF9-E979C1DF30DEQ24679275-2F333E4A-4F0F-4312-B98C-519491C06D09Q24799770-C0E5A2AF-0176-408D-A991-2533FC92CE8DQ24803143-ABEB159F-5E5E-4D69-82D5-5BC295B44EBFQ27000230-6DE26E90-8E71-46F7-9B0C-2C7E427110ECQ28073154-418445CC-FF63-4BA3-8A5C-A0DA8FE82A5CQ34130146-6B6EAF03-ADD3-482A-A225-6FA995A10CDCQ34583238-D5A751D3-6DBF-4240-85EE-17AABDBFD892Q36076876-2A3F5984-63E9-448F-92D7-FC590DBDBB02Q36273615-74695EC6-489E-436B-965C-7687FE98355FQ36585665-ABF96E37-B703-4051-8A6C-07E4F136588EQ37126006-2D282F3C-04AE-4CB8-9C14-F4DBFA33043FQ37316601-FE0ED9C6-641F-4607-A215-A12F88CBA8F9Q37847059-FF0B3469-3B24-4319-8AE8-8388943CBE89Q38066487-DBA814A4-AAE1-44D8-AD5D-49E7F8A29375Q38088820-D3602292-C4CD-4CAA-9A54-010CF07ACCE3Q38424758-E0B839B9-EFAD-43E1-A819-E090748D4C35Q39369202-FF28F585-C6F5-44A8-849D-11A9E4D22C97Q39775890-6EC0F0CC-F074-4DC5-80C4-BEA3E0DBC549Q40690556-F8389D8D-B30E-4D2F-9E29-C9A47CB0DB2CQ40871587-CC348F2A-6D2F-4661-B541-49726412DB3AQ41218950-8BED9FCE-7995-4B8A-8698-1C754DB53D32Q41261263-4259FE95-F05B-4A54-A703-F81CE07CBA9FQ41654262-EF81A33B-B3B0-4E8C-9767-62407BAF7AC8Q42116623-FAAB371D-CE20-4C33-B211-B1F80988F9D0Q42125853-6E544B72-BF88-4990-917B-EF460C9E30CFQ42155875-F47A0196-B22E-4975-8B4A-10EA52FA80EFQ43824617-AA42DE23-9CC4-41FF-95D2-D2EF3A8AA738Q50004232-AACAA304-F1D5-4AFC-880D-644EA422D333Q55546622-E9191B1B-1F02-4BBF-811F-E29570A6BC62
P2860
description
1965 nî lūn-bûn
@nan
1965 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
A Lymphocyte-stimulating Factor produced in vitro
@ast
A Lymphocyte-stimulating Factor produced in vitro
@en
A lymphocyte-stimulating factor produced in vitro.
@nl
type
label
A Lymphocyte-stimulating Factor produced in vitro
@ast
A Lymphocyte-stimulating Factor produced in vitro
@en
A lymphocyte-stimulating factor produced in vitro.
@nl
altLabel
A lymphocyte-stimulating factor produced in vitro.
@ast
A lymphocyte-stimulating factor produced in vitro.
@en
prefLabel
A Lymphocyte-stimulating Factor produced in vitro
@ast
A Lymphocyte-stimulating Factor produced in vitro
@en
A lymphocyte-stimulating factor produced in vitro.
@nl
P2093
P356
P1433
P1476
A Lymphocyte-stimulating Factor produced in vitro
@en
A lymphocyte-stimulating factor produced in vitro.
@en
P2093
L. D. MACLEAN
MacLean LD
P2888
P304
P356
10.1038/208795A0
P407
P577
1965-11-01T00:00:00Z
1965-11-20T00:00:00Z